Human papillomavirus infection associated with cervical cancer and other malignancies

Registo de metadados completa
Campo DCValoridioma
dc.contributor(LG) Lab. Genéticapt_BR
dc.contributor(LABV) Lab. Biotecnologia Viralpt_BR
dc.contributor.authorSakauchi, Dircept_BR
dc.contributor.authorCianciarullo, Aurora Marquespt_BR
dc.date.accessioned2023-12-18T13:16:40Z-
dc.date.available2023-12-18T13:16:40Z-
dc.date.issued2023pt_BR
dc.identifier.citationSakauchi D, Cianciarullo AM. Human papillomavirus infection associated with cervical cancer and other malignancies. GSC Biol Pharm Sci. 2023 Oct; 25(01):164–177. doi:10.30574/gscbps.2023.25.1.0430.pt_BR
dc.identifier.urihttps://repositorio.butantan.gov.br/handle/butantan/5198-
dc.description.abstractHuman papillomavirus (HPV) consists in a great clinical importance worldwide, being involved in the most frequent sexually transmitted viral infection, genital warts, with high incidence in both men and women. Furthermore, HPV can also develop a broad spectrum of cancers, the most common is cervical cancer, being one of the main causes of morbidity and mortality in women worldwide, especially in low-and middle-income countries (LMICs). Here we discuss the importance of cervical cancer prevention and others related cancers caused by HPV, information about HPV vaccines, evaluation of single-dose use, low vaccination coverage, as well as other topics regarding viral transmission, biology, and epidemiology, aiming for the reduction of cervical carcinoma cases and others HPV associated diseases, reducing infections and death in the world as regarding to HPV, through the wide people immunization.pt_BR
dc.description.sponsorship(FAPESP) Fundação de Amparo à Pesquisa do Estado de São Paulopt_BR
dc.format.extent164–177pt_BR
dc.language.isoEnglishpt_BR
dc.relation.ispartofGSC Biological and Pharmaceutical Sciencespt_BR
dc.rightsOpen accesspt_BR
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/pt_BR
dc.titleHuman papillomavirus infection associated with cervical cancer and other malignanciespt_BR
dc.typeArticlept_BR
dc.rights.licenseCC BYpt_BR
dc.identifier.doi10.30574/gscbps.2023.25.1.0430pt_BR
dc.identifier.citationvolume25pt_BR
dc.identifier.citationissue1pt_BR
dc.subject.keywordHuman papillomaviruspt_BR
dc.subject.keywordHPVpt_BR
dc.subject.keywordcervical cancerpt_BR
dc.subject.keywordProphylaxispt_BR
dc.subject.keywordvaccinept_BR
dc.subject.keywordimmunizationpt_BR
dc.relation.ispartofabbreviatedGSC Biol Pharm Scipt_BR
dc.identifier.citationabntv. 25, n. 01, p. 164–177pt_BR
dc.identifier.citationvancouver2023 Oct; 25(01):164–177pt_BR
dc.contributor.butantanSakauchi, Dirce|:Pesquisador|:(LG) Lab. Genética|:PrimeiroAutor|:Autor de correspondênciapt_BR
dc.contributor.butantanCianciarullo, Aurora Marques|:Pesquisador|:(LABV) Lab. Biotecnologia Viral|:Autor de correspondênciapt_BR
dc.sponsorship.butantan(FAPESP) Fundação de Amparo à Pesquisa do Estado de São Paulo¦¦pt_BR
dc.identifier.bvsccBR78.1pt_BR
dc.identifier.bvsdbIBProdpt_BR
dc.description.dbindexedYespt_BR
item.openairetypeArticle-
item.fulltextCom Texto completo-
item.grantfulltextopen-
item.languageiso639-1English-
crisitem.author.dept#PLACEHOLDER_PARENT_METADATA_VALUE#-
crisitem.author.dept#PLACEHOLDER_PARENT_METADATA_VALUE#-
crisitem.author.orcid0000-0002-3203-5510-
crisitem.author.orcid0000-0002-0676-9190-
crisitem.journal.journalissn#PLACEHOLDER_PARENT_METADATA_VALUE#-
crisitem.journal.journaleissn#PLACEHOLDER_PARENT_METADATA_VALUE#-
Aparece nas Coleções:Artigos


Mostrar registro simples do item

Este item está licenciada sob uma Licença Creative Commons Creative Commons